Laurent Fauchier
#153,797
Most Influential Person Now
Researcher
Laurent Fauchier's AcademicInfluence.com Rankings
Laurent Fauchiercomputer-science Degrees
Computer Science
#8291
World Rank
#8716
Historical Rank
Machine Learning
#3358
World Rank
#3398
Historical Rank
Artificial Intelligence
#3655
World Rank
#3707
Historical Rank
Laurent Fauchiermathematics Degrees
Mathematics
#7093
World Rank
#9712
Historical Rank
Group Theory
#103
World Rank
#129
Historical Rank
Algebra
#304
World Rank
#425
Historical Rank
Measure Theory
#1860
World Rank
#2272
Historical Rank
Download Badge
Computer Science Mathematics
Laurent Fauchier's Degrees
- PhD Physics Université Paris Cité
Why Is Laurent Fauchier Influential?
(Suggest an Edit or Addition)Laurent Fauchier's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). (2020) (3378)
- Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (2014) (550)
- Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration (2017) (417)
- A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. (2011) (293)
- Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary (2016) (263)
- Bleeding risk assessment and management in atrial fibrillation patients (2011) (247)
- Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. (2018) (225)
- Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy: a prognostic study with fourier phase analysis of radionuclide angioscintigraphy. (2002) (220)
- Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. (2008) (217)
- Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. (2011) (216)
- 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries endorsed by APHRS/HRS/LAHRS (2018) (203)
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. (2016) (193)
- EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. (2020) (186)
- 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European (2018) (183)
- Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. (1999) (157)
- Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society (2018) (157)
- Wilkoff BL, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. (2017) (144)
- Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. (2000) (141)
- Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. (2019) (134)
- Potential Cost Savings by Telemedicine‐Assisted Long‐Term Care of Implantable Cardioverter Defibrillator Recipients (2005) (131)
- Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (2015) (128)
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. (2016) (121)
- Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation. (2014) (119)
- Causes of Death and Influencing Factors in Patients with Atrial Fibrillation. (2016) (118)
- Stroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project (2015) (116)
- Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (2013) (116)
- Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry (2018) (115)
- Atrial fibrillation (2016) (111)
- Genetic Association Study Identifies HSPB7 as a Risk Gene for Idiopathic Dilated Cardiomyopathy (2010) (110)
- Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project (2012) (108)
- Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (2012) (108)
- Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiologí (2017) (105)
- Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1 (2010) (103)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (103)
- Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials (2013) (93)
- EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. (2019) (87)
- How to define valvular atrial fibrillation? (2015) (82)
- Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project (2012) (82)
- Prognosis and guideline-adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire Valley Atrial Fibrillation Project. (2011) (78)
- Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. (2012) (75)
- Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. (2009) (75)
- Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study (2015) (74)
- Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement. (2020) (74)
- AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. (2021) (73)
- Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study (2010) (70)
- 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. (2022) (68)
- Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke (2016) (68)
- Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis (2019) (67)
- Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. (2011) (66)
- A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (2014) (66)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017) (65)
- Reliability of QRS duration and morphology on surface electrocardiogram to identify ventricular dyssynchrony in patients with idiopathic dilated cardiomyopathy. (2003) (65)
- Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Hear (2019) (65)
- 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. (2019) (64)
- Rhythm control in atrial fibrillation (2016) (62)
- Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis (2018) (62)
- Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated? (2016) (60)
- C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study (2019) (60)
- Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project. (2016) (59)
- Prognostic value of programmed ventricular stimulation in Brugada syndrome according to clinical presentation: an updated meta-analysis of worldwide published data. (2013) (58)
- The wearable cardioverter-defibrillator: current technology and evolving indications (2017) (57)
- Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry. (2020) (56)
- Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. (2015) (56)
- Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation (2013) (56)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (2018) (56)
- Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry (2016) (55)
- Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review (2017) (54)
- Long-term prognostic value of time domain analysis of signal-averaged electrocardiography in idiopathic dilated cardiomyopathy. (2000) (54)
- Prognosis in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score = 0 in a Community‐Based Cohort Study (2012) (53)
- Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. (2009) (53)
- Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion. (2021) (52)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? (2018) (51)
- Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure. (2009) (50)
- Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project. (2014) (50)
- Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Associatio (2019) (49)
- Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances (2003) (48)
- Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people. (2013) (48)
- Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. (2014) (47)
- Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. (2012) (45)
- Physical training increases heart rate variability in healthy prepubertal children (2002) (45)
- Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study (2015) (43)
- Implantable loop recorder for recurrent syncope: influence of cardiac conduction abnormalities showing up on resting electrocardiogram and of underlying cardiac disease on follow-up developments. (2008) (43)
- Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation (2016) (43)
- Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications (2018) (42)
- Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry. (2019) (42)
- Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier. (2014) (41)
- Ventricular Arrhythmia Factors in Mitral Valve Prolapse (1994) (39)
- Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction. (2014) (37)
- Comparison of the beneficial effect of beta‐blockers on mortality in patients with ischaemic or non‐ischaemic systolic heart failure: A meta‐analysis of randomised controlled trials (2007) (36)
- History of thyroid disorders in relation to clinical outcomes in atrial fibrillation. (2015) (35)
- Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable—Prévention Primaire registry (2017) (35)
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing☆☆☆ (2016) (34)
- Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study. (2016) (34)
- Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II. (2015) (32)
- Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis (2016) (32)
- 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. (2020) (32)
- Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register (2010) (31)
- Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation (2019) (30)
- Association between heart rate-corrected QT interval and coronary risk factors in 2,894 healthy subjects (the DESIR Study). Data from an Epidemiological Study on the Insulin Resistance syndrome. (2000) (30)
- Diagnosis of arrhythmogenic right ventricular cardiomyopathy by fourier analysis of gated blood pool single-photon emission tomography. (1998) (29)
- The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications (2011) (28)
- 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing (2020) (28)
- Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention. (2016) (28)
- Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation. (2015) (28)
- Long-Term Outcome and Valve Surgery for Infective Endocarditis in the Systematic Analysis of a Community Study. (2016) (28)
- Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France (2015) (27)
- Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study. (2017) (27)
- Acute Myocardial Infarction Following Oral Methyl-Ergometrine Intake (2009) (27)
- Very long-term survival and late sudden cardiac death in cardiac resynchronization therapy patients. (2019) (27)
- European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). (2017) (27)
- The SAMe-TT2R2 score and quality of anticoagulation in AF: Can we predict which patient benefits from anticoagulation? (2015) (27)
- Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation (2014) (27)
- Outcomes after ablation for typical atrial flutter (from the Loire Valley Atrial Fibrillation Project). (2014) (26)
- The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the loire valley atrial fibrillation project. (2015) (26)
- Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods? (1999) (25)
- Incidence, characteristics, and mortality of infective endocarditis in France in 2011 (2019) (25)
- CO inhalation at dose corresponding to tobacco smoke worsens cardiac remodeling after experimental myocardial infarction in rats. (2005) (25)
- Evaluation of 5 Prognostic Scores for Prediction of Stroke, Thromboembolic and Coronary Events, All-Cause Mortality, and Major Adverse Cardiac Events in Patients With Atrial Fibrillation and Coronary Stenting. (2016) (25)
- Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis (2020) (25)
- Effect of verapamil on QT interval dynamicity. (1999) (25)
- Major Bleeding and Risk of Death after Percutaneous Native Kidney Biopsies: A French Nationwide Cohort Study. (2020) (25)
- Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation (2017) (24)
- Epilepsy, Brugada syndrome and the risk of sudden unexpected death (2000) (24)
- Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty. (2014) (24)
- Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death (2017) (24)
- Incidence and predictive factors of atrial fibrillation after ablation of typical atrial flutter (2009) (23)
- Cardiac resynchronization in chronic heart failure: some considerations about the cost-effectiveness. (2003) (23)
- Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study (2021) (23)
- Management of Atrial Tachyarrhythmias: Benefits of Pacemaker Diagnostics (2003) (23)
- Electrical storm reversible by isoproterenol infusion in a striking case of early repolarization (2009) (23)
- Abnormal Nocturnal Heart Rate Variability and QT Dynamics in Patients with Brugada Syndrome (2007) (22)
- Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: Results of a European collaboration assembling more than 2000 patients. (2013) (22)
- Usefulness of a clinical risk score to predict the response to cardiac resynchronization therapy. (2018) (22)
- C0589: Relationship of the SAME-TT2R2 Score to Poor Quality Anticoagulation, Stroke, Clinically Relevant Bleeding and Mortality in Patients with Atrial Fibrillation (2014) (22)
- Response by Deharo et al to Letter Regarding Article, "Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis: Data From a Nationwide Analysis". (2020) (22)
- Alcoholic cardiomyopathy and ventricular arrhythmias. (2003) (21)
- Ventricular Dyssynchrony and Risk Markers of Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy: (2003) (21)
- Implantable Loop Recorder in Clinical Practice (2011) (21)
- Prognosis in patients with atrial fibrillation and a presumed “temporary cause” in a community-based cohort study (2017) (21)
- Segmental wall motion abnormalities in idiopathic dilated cardiomyopathy and their effect on prognosis. (2004) (20)
- European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). (2018) (20)
- Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure. (2014) (20)
- Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort. (2017) (20)
- Time‐Domain Signal‐Averaged Electrocardiogram in Nonischemic Ventricular Tachycardia (1996) (20)
- Prediction of Nonarrhythmic Mortality in Primary Prevention Implantable Cardioverter-Defibrillator Patients With Ischemic and Nonischemic Cardiomyopathy. (2015) (20)
- Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow-up (2015) (20)
- Pacemaker Implantation After Balloon‐ or Self‐Expandable Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis (2020) (20)
- Heart Rate Variability Before Ventricular Arrhythmias in Patients with Coronary Artery Disease and an Implantable Cardioverter Defibrillator (2003) (20)
- Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement. (2020) (20)
- Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence? (2016) (19)
- Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation (2020) (19)
- Mortality After Atrioventricular Nodal Radiofrequency Catheter Ablation With Permanent Ventricular Pacing in Atrial Fibrillation: Outcomes From a Controlled Nonrandomized Study (2016) (19)
- High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction (2018) (19)
- Comparison of frequency of major adverse events in patients with atrial fibrillation receiving bare-metal versus drug-eluting stents in their coronary arteries. (2012) (19)
- Galectin-3 in patients undergoing ablation of atrial fibrillation (2014) (18)
- QT dispersion in nonischemic dilated cardiomyopathy. A long‐term evaluation (2005) (18)
- Device-Related Thrombus After Left Atrial Appendage Closure (2021) (18)
- Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie. (2016) (17)
- Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review (2018) (17)
- Depression and heart failure. (2004) (17)
- Significance of late ventricular potentials in myotonic dystrophy. (1999) (17)
- Heart rate variability in rats acclimatized to high altitude. (2003) (17)
- 'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). (2019) (17)
- Comparison of degree of stenosis and plaque volume for the assessment of carotid atherosclerosis using 2-D ultrasound. (2009) (16)
- Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation (2019) (16)
- Heart rate variability in rats with chronic hypoxic pulmonary hypertension. (2006) (16)
- The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists. (2015) (16)
- Consensus d’experts de la Société française de gériatrie et gérontologie et de la Société française de cardiologie, sur la prise en charge de la fibrillation atriale du sujet âgé (2013) (16)
- [Expert consensus of the French society of geriatrics and gerontology and the French society of cardiology on the management of atrial fibrillation in elderly people]. (2013) (15)
- Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection (2020) (15)
- New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction. (2015) (15)
- Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure (2018) (15)
- Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry (2021) (15)
- Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry (2015) (15)
- Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator (2020) (15)
- Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor (2016) (14)
- Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France. (2018) (14)
- Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice (2017) (14)
- Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification. (2018) (14)
- Position paper concerning the competence, performance and environment required in the practice of complex ablation procedures. (2019) (13)
- Metabolically healthy obesity and cardiovascular events: A nationwide cohort study (2021) (13)
- Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study. (2019) (13)
- Junctional Rhythm During Slow Pathway Radiofrequency Ablation in Patients with Atrioventricular Nodal Reentrant tachycardia: Beat‐to‐Beat Analysis and Its Prognostic Value in Relation to Electrophysiologic and Anatomic Parameters (2000) (13)
- The CHOICE Randomized Clinical Trial. (2020) (13)
- Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation. (2019) (12)
- Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study. (2010) (12)
- Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification. (2016) (12)
- Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021) (12)
- Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry (2021) (12)
- Direct implication of carbon monoxide in the development of heart failure in rats with cardiac hypertrophy subjected to air pollution (2007) (12)
- Tachycardies ventriculaires idiopathiques monomorphes (1996) (12)
- Cohort profile The ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry. (2020) (11)
- Incomplete recovery of mechanical and endocrine left atrial functions one month after electrical cardioversion for persistent atrial fibrillation: a pilot study (2014) (11)
- Ventricular pacing through coronary sinus in patients with tricuspid prosthesis. (2010) (11)
- Management of antithrombotic therapy in atrial fibrillation patientspresentingwith acutecoronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart (2014) (11)
- Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis (2021) (11)
- Atrial fibrillation and renin-angiotensin-aldosterone system: believe it or not. (2011) (10)
- Prophylactic implantable cardioverter-defibrillator in the very elderly. (2019) (10)
- International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) (2019) (10)
- Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention. (2020) (10)
- Benefits of an early management of palpitations (2018) (10)
- Comparative study of atrial vulnerability in patients with unexplained ischemic stroke or lone atrial paroxysmal fibrillation. (2003) (9)
- Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus (2021) (9)
- Delayed contraction area responsible for sustained ventricular tachycardia in an arrhythmogenic right ventricular cardiomyopathy: Demonstration by fourier analysis of SPECT equilibrium radionuclide angiography (2000) (9)
- Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation. (2020) (9)
- Effect of Flecainide on Heart Rate Variability in Subjects Without Coronary Artery Disease or Congestive Heart Failure (1998) (9)
- Recommendations for the implantation of leadless pacemakers from the French Working Group on Cardiac Pacing and Electrophysiology of the French Society of Cardiology. (2018) (9)
- Fourier phase analysis of SPECT equilibrium radionuclide angiography in symptomatic patients with mitral valve prolapse without significant mitral regurgitation: Assessment of biventricular functional abnormalities suggesting a cardiomyopathy (2000) (9)
- Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France (2020) (8)
- Risk factors and outcomes of early acute kidney injury in infective endocarditis: a retrospective cohort study. (2020) (8)
- Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions (2020) (8)
- Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project. (2015) (8)
- Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis (2021) (8)
- Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure? (2015) (8)
- Adherence to the "Atrial fibrillation Better Care" (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry. (2022) (8)
- Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. (2010) (8)
- Risk of myocardial infarction and death in patients with atrial fibrillation treated with dabigatran or vitamin K antagonists (2016) (8)
- New antithrombotic drugs and European approval processes (2011) (8)
- Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke (2017) (8)
- Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Native Heart Valves. (2017) (8)
- Revascularization algorithm in acute STEMI should take into account age. (2007) (8)
- CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis. (2016) (8)
- 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter‐defibrillator programming and testing (2019) (7)
- The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review (2021) (7)
- Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators Groupe de rythmologie et stimulation cardiaque de la Société française de cardiologie et Société française de gériatrie et gérontologie. (2016) (7)
- European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? (2018) (7)
- Outcomes in nonagenarians undergoing transcatheter aortic valve implantation (TAVI): data from a nationwide analysis. (2019) (7)
- Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry (2022) (7)
- Épreuve de lecture critique d'article scientifique des épreuves classantes nationales : pertinence de la correction (2007) (7)
- Galectin-3 predicts response and outcomes after cardiac resynchronization therapy (2018) (7)
- Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation (2021) (7)
- Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. (2022) (7)
- Myocardial Infarction after Kidney Transplantation: A Risk and Specific Profile Analysis from a Nationwide French Medical Information Database (2020) (7)
- Searching for Atrial Fibrillation Poststroke (2019) (7)
- Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging on magnetic resonance imaging in patients with cardiac electronic implantable devices. (2020) (6)
- Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Prosthetic or Bioprosthetic Heart Valves. (2017) (6)
- Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry. (2021) (6)
- [Left atrial appendage closure in atrial fibrillation]. (2013) (6)
- Incident heart failure, arrhythmias and cardiovascular outcomes with sodium‐glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database (2022) (6)
- Major Adverse Events With Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation. (2019) (6)
- Outcomes associated with pacemaker implantation following transcatheter aortic valve replacement. A nationwide cohort study. (2021) (6)
- Segmental Wall Motion Abnormality Analyzed by Equilibrium Radionuclide Angiography and Improvement in Ventricular Function by Cardiac Resynchronization Therapy (2007) (6)
- Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation (2017) (5)
- Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants (2021) (5)
- Different criteria of cardiac resynchronization therapy and their prognostic value for worsening heart failure or major arrhythmic events in patients with idiopathic dilated cardiomyopathy. (2006) (5)
- Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. (2021) (5)
- Left Atrial Appendage Closure in Atrial Fibrillation. (2018) (5)
- Genome wide association analysis in dilated cardiomyopathy reveals two new key players in systolic heart failure on chromosome 3p25.1 and 22q11.23 (2020) (5)
- Localization of Left Ventricular Lead Electrodes in Relation to Myocardial Scar in Patients Undergoing Cardiac Resynchronization Therapy (2018) (5)
- Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation. (2018) (5)
- Mitral valve prolapse and cardiac arrhythmias. (2002) (5)
- Valve-in-valve transcatheter aortic valve implantation after failed surgically implanted aortic bioprosthesis versus native transcatheter aortic valve implantation for aortic stenosis: Data from a nationwide analysis. (2020) (5)
- Early mortality after implantable cardioverter defibrillator: Incidence and associated factors. (2019) (5)
- Prognosis in Familial Atrial Fibrillation (2016) (5)
- Impact of gender on relative rates of cardiovascular events in patients with diabetes. (2021) (5)
- Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients. (2017) (5)
- Stroke prevention in patients with atrial flutter: many questions still unanswered. (2018) (4)
- Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (4)
- Does defibrillation testing influence outcomes after CRT-D implantation? A cause-of-death analysis from the DAI-PP study. (2016) (4)
- Nonsustained Ventricular Tachycardia at the Time of Implantation Predicts Appropriate Therapies on Rapid Ventricular Arrhythmia in Primary Prevention Patients With Nonischemic Cardiomyopathy: Results From the Very-High-Rate Registry. (2017) (4)
- Risk Scores in ST-Segment Elevation Myocardial Infarction Patients with Refractory Cardiogenic Shock and Veno-Arterial Extracorporeal Membrane Oxygenation (2021) (4)
- Wearable Cardioverter–Defibrillator after Myocardial Infarction. (2019) (4)
- Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus. (2021) (4)
- Cholesterol levels and cholesterol lowering in idiopathic dilated cardiomyopathy. (2005) (4)
- Temporal Relationship between Atrial Fibrillation and Heart Failure Development Analysis from a Nationwide Database (2021) (4)
- The SAMe-TT 2 R 2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists (2015) (4)
- Programming implantable cardioverter-defibrillators in primary prevention: higher or later. (2014) (4)
- Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants (2013) (4)
- Clinical outcomes with digoxin vs. beta‐blocker for heart rate control in permanent atrial fibrillation with heart failure (2021) (4)
- Epidemiology and impact of frailty in patients with atrial fibrillation in Europe. (2022) (4)
- Research in resuscitation from cardiac arrest: where should we go from here? (2007) (4)
- Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. Data from the international CLARIFY registry (2013) (4)
- Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry. (2021) (4)
- ICD Implantation in Patients with Nonischemic Heart Failure. (2017) (4)
- Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view (2019) (4)
- Predicting Clinical and Echocardiographic Response After Cardiac Resynchronization Therapy With a Score Combining Clinical, Electrocardiographic, and Echocardiographic Parameters. (2017) (4)
- Management of sustained arrhythmias for patients with cardiogenic shock in intensive cardiac care units. (2019) (4)
- Multisite pacing via a quadripolar lead for cardiac resynchronization therapy (2019) (4)
- Renal impairment and stroke risk assessment in patients with atrial fibrillation (2013) (4)
- Cost-effectiveness of ICDs. (2006) (4)
- Dépistage et implications cliniques de la fibrillation atriale silencieuse (2017) (3)
- Pacemaker implantation after balloon- or self-expandable transcatheter aortic valve replacement in patients with aortic stenosis (2020) (3)
- Amazing Sinus Cardiac Arrest (2001) (3)
- 482Direct oral anticoagulant rivaroxaban in very old and frail patients: A one-year prospective follow-up of a large-scale cohort (SAFIR-AC) (2019) (3)
- Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry. (2022) (3)
- Arythmies de la cardiomyopathie hypertrophique primitive. (2003) (3)
- [Correcting the critical reading test of the national ranking examination]. (2007) (3)
- Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry. (2022) (3)
- Risk of ischemic stroke in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis (2020) (3)
- Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry (2022) (3)
- Predicting outcome after cardiac resynchronisation therapy defibrillator implantation: the cardiac resynchronisation therapy defibrillator Futility score (2022) (3)
- Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke? (2016) (3)
- Antidiabetic drugs use and new-onset atrial fibrillation in patients with diabetes mellitus (2021) (3)
- Evaluation du coût des complications des défibrillateurs cardiaques automatiques implantables (2007) (3)
- SAFIR cohort: One-year prospective follow-up of very old and frail patients treated with direct oral anticoagulant, rivaroxaban (2020) (3)
- [Conduction defects and arrhythmias in peripheral myopathies]. (2004) (3)
- Bleeding risk in patients treated with dabigatran or vitamin K antagonist for atrial fibrillation: A meta analysis of adjusted analysis in routine practice settings. (2016) (3)
- Épanchement péricardique révélateur d'une insuffisance cardiaque à débit élevé par carence en thiamine chez un adulte jeunePericardial extravasation as an indicator of congestive heart failure due to thiamine deficiency in a young adult: a case report. (2000) (3)
- Idarucizumab for Reversion of Anticoagulant Effect in Daily Practice (2019) (3)
- Indications du défibrillateur cardiaque automatique implantable dans le syndrome de Brugada (2005) (3)
- Review of novel therapeutics by three regulatory agencies. (2012) (3)
- Ventricular Tachycardia in Heterotopic Heart Transplantation (2007) (3)
- Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis. (2020) (3)
- Three case reports of involuntary muscular movements as adverse reactions to sacubitril/valsartan (2018) (3)
- The atrial fibrillation epidemic: a validated diagnosis, or not? (2014) (3)
- Troubles conductifs et troubles du rythme dans les myopathies périphériques (2004) (2)
- [When do you implant a pacemaker in myotonic dystrophy?]. (2011) (2)
- Arrhythmias and Sudden Death in Patients with Mitral Valve Prolapse (1997) (2)
- Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: a meta-analysis of randomized controlled trials. (2014) (2)
- Simultaneous cardiocerebral embolization in patients with atrial fibrillation. (2020) (2)
- Cardiac Arrhythmias in Mitral Valve Prolapse: Update (1999) (2)
- Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry (2022) (2)
- Abstract 20559: Effectiveness and Safety of Rivaroxaban 15 mg Compared With Vitamin K Antagonists in Very Elderly Patients With Atrial Fibrillation, a Matched Cohort Study in the French Nationwide Claims Database SNIIRAM (2017) (2)
- Timing of Coronary Revascularization and Transcatheter Aortic Valve Replacement: An Observational Nationwide Cohort Analysis. (2021) (2)
- Focus on stereotactic radiotherapy: A new way to treat severe ventricular arrhythmias? (2021) (2)
- Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry (2021) (2)
- Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. (2021) (2)
- How to estimate the potential clinical benefit associated with left atrial appendage closure? (2020) (2)
- Xafran, a drug utilization study of rivaroxaban in stroke prevention in atrial fibrillation in France using a claim database. (2018) (2)
- Abstract 18129: Risk Factors of the Progression from Paroxysmal or Persistent to Permanent Atrial Fibrillation. Evaluation of the HATCH Score in a Cohort of Unselected Patients. (2010) (2)
- The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia: insights from the European Survey on Arrhythmogenic Cardiomyopathy. (2021) (2)
- Bleeding risks with frailty and multimorbidity in patients with atrial fibrillation. A nationwide analysis of 1.4 million subjects (2020) (2)
- Long-term follow-up of patients with tetralogy of fallot and implantable cardioverter defibrillator–The DAI-T4F nationwide registry (2021) (2)
- Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) registry (2021) (2)
- Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al. (2013) (2)
- Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry (2022) (2)
- The Prognosis of Baseline Mitral Regurgitation in Patients with Transcatheter Aortic Valve Implantation (2021) (2)
- Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry. (2022) (2)
- A nice case of swallowing-induced atrial tachycardia with successful radiofrequency ablation of an ectopic focus in right atrium. (2007) (2)
- A clinical trial of ICD programming. (2013) (2)
- Why and how to screen for atrial fibrillation (2018) (2)
- Interventricular delay measurement using equilibrium radionuclide angiography before resynchronization therapy should be performed outside the area of segmental wall motion abnormalities (2011) (2)
- Aspects généraux et réglementaires de la matériovigilance des stimulateurs et des défibrillateurs cardiaques (2005) (2)
- Quand implanter un stimulateur cardiaque dans la maladie de Steinert (2011) (2)
- Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study (2022) (1)
- 0018 : Antithrombotic management in patients with atrial fibrillation undergoing stent implantation: An assessment of the ESC guidelines adherence (2015) (1)
- 1964 Long-term prognostic value of criteria of cardiac resynchronization therapy for cardiac death and heart transplantation in idiopathic dilated cardiomyopathy (2003) (1)
- Apixaban after acute coronary syndrome. (2011) (1)
- World trade center attack and cardiac events : Fact or fear? Authors' reply (2005) (1)
- How is Contact Force implemented in routine clinical practice? Results from a French National and Monaco Survey (2019) (1)
- Comparison of Surgical Ventricular Septal Reduction to Alcohol Septal Ablation Therapy in Patients with Hypertrophic Cardiomyopathy. (2022) (1)
- P5675Ischemic stroke in patient with sinus node disease in comparison to atrial fibrillation, bradycardia-tachycardia syndrome and other cardiac conditions: a nationwide cohort-study (2019) (1)
- 684 Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (2021) (1)
- Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry (2022) (1)
- [Diagnostic criteria for ventricular tachycardia]. (2004) (1)
- Compared Impact of Diabetes on the Risk of Heart Failure from Acute Myocardial Infarction to Chronic Coronary Artery Disease. (2021) (1)
- [Postmarketing surveillance in patients with cardiac pace-makers or automatic implantable defibrillators]. (2005) (1)
- Digoxin and morality in idiopathic dilated cardiomyopathy (2000) (1)
- 486Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study (2019) (1)
- Incomplete recovery of mechanical and endocrine left atrial functions one month after electrical cardioversion for persistent atrial fibrillation: a pilot study (2014) (1)
- Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry. (2020) (1)
- Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. (2021) (1)
- Risks of thromboembolism, mortality and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study (2021) (1)
- [Risk stratification in atrial and ventricular arrhythmias]. (2006) (1)
- Erratum to ‘2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing’ [Journal of Arrhythmia 32/1 (2016) 1–28] (2016) (1)
- Granulomatous mass adherent to a patent foramen ovale occluder. (2013) (1)
- Data standards for atrial fibrillation/flutter and catheter ablation: The European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart). (2022) (1)
- Alcohol and Cardiac Structure: Less Is Better. (2018) (1)
- Non-antiarrhythmic drugs for the prevention of atrial fibrillation: ACEIs, ARBs, statins and PUFAs. (2013) (1)
- EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). (2023) (1)
- Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase). (2019) (1)
- Three-dimensional interlead distance predicts response and outcomes after cardiac resynchronization therapy. (2017) (1)
- New antithrombotic drugs for atrial fibrillation: caution is needed – Authors' reply (2012) (1)
- Apixaban after Acute Coronary Syndrome (2011) (1)
- Outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement (2020) (1)
- How should we treat patients with atrial fibrillation and a CHADS2 score of 1 (2010) (1)
- Risk markers of ventricular arrhythmias and fourier phase analysis of radionuclide angioscintigraphy to evaluate ventricular asynchrony and prognosis in idiopathic dilated cardiomyopathy (2002) (1)
- Features of clinical complexity in european patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (2022) (1)
- Abstract 14523: Two-Year Benefit-Risk of Standard and Reduced Doses of Rivaroxaban versus Vitamin-K Antagonists in Non-Valvular Atrial Fibrillation: A Cohort Study in the French Nationwide Claims Database (2018) (1)
- Statins and Atrial Fibrillation – Developments and Advances (2008) (1)
- Beta-blockers and ventricular arrhythmias in dilated cardiomyopathy. (2000) (1)
- World Trade Center attack and cardiac events: fact or fear? (2005) (1)
- Extrasystoles auriculaires, jonctionnelles et ventriculaires (2004) (1)
- Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry (2022) (1)
- Outcomes of digoxin vs. beta-blocker in AF: report from ESC-EHRA EORP-AF Long-Term General Registry. (2021) (1)
- Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry (2022) (1)
- Abstract 14: Use of an Insertable Cardiac Monitor to Detect Atrial Fibrillation is Cost Effective in Patients with Cryptogenic Stroke (2015) (1)
- 3874Implantable cardiac defibrillator in the setting of tetralogy of fallot: data from the DAI-T4F National Registry (2017) (1)
- Major Bleeding of Transjugular Native Kidney Biopsies. A French Nationwide Cohort Study (2021) (1)
- Risk of ischemic stroke in patients with atrial fibrillation and concomitant hyperthyroidism: a nationwide cohort study (2021) (1)
- A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study. (2023) (1)
- Valve‐in‐valve transcatheter aortic valve replacement or re‐surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta‐analysis of short and midterm results (2022) (1)
- High risk in atrial fibrillation following an ablation procedure: the wide usefulness of the CHADS(2) score. (2012) (1)
- New insights on the pathogenesis of atrial fibrillation in acute myocardial infarction: Data from the “ObseRvatoire des Infarctus de Côte d’Or” (RICO) survey (2019) (1)
- Prediction of systemic septic embolism in patients with left-sided infective endocarditis (2017) (1)
- 59-01: SafeR is associated with a risk reduction of first-onset AF in patients with atrio-ventricular blocks: results from the ANSWER study (2016) (1)
- Fear does not avoid the danger! (2020) (1)
- 13. Brugada Syndrome, LQTS, and ARVC13.5 Abnormal QT Dynamics and Nocturnal Temporal QT Dispersion in Brugada Syndrome (2005) (1)
- Insuffisance rénale aiguë au cours de la prise en charge des endocardites infectieuses : incidence, facteurs de risques et pronostic (2018) (1)
- Reply: Device-Related Thrombus After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation. (2018) (1)
- PREDICTORS OF INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY (2017) (1)
- Stratification du risque dans les troubles du rythme auriculaire et ventriculaire (2006) (1)
- Coronary Artery Embolism and Acute Coronary Syndrome: A critical appraisal of existing data. (2022) (1)
- Acute Dental Periapical Abscess and New-Onset Atrial Fibrillation: A Nationwide, Population-Based Cohort Study (2021) (1)
- Prognosis of Type 2 Myocardial Infarction Patients Implanted With a Prophylactic Defibrillator (from the Very-High-Rate Registry). (2020) (1)
- [Prevalence of atrial arrhythmia in 48 hypertensive patients: research of predictive criteria]. (1992) (1)
- Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease. (2020) (1)
- Does left atrial appendage morphology have any impact on the results of percutaneous closure? (2020) (1)
- Exploring the temporal relationship between atrial fibrillation and heart failure development. Analysis from a nationwide database (2020) (1)
- A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project (2013) (1)
- Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the ESC-EHRA EORP AF general long-term registry. (2022) (1)
- Variabilité du rythme sinusal chez des sujets paraplégiques hauts (2000) (1)
- Atrial fibrillation with or without structural abnormalities. Analysis from a nationwide database (2020) (1)
- [Pericardial extravasation as an indicator of congestive heart failure due to thiamine deficiency in a young adult]. (2000) (1)
- THYROID DISORDERS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION IN A COHORT STUDY (2014) (1)
- Rivaroxaban in Stable Cardiovascular Disease. (2018) (1)
- Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study. (2022) (1)
- Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients (2023) (1)
- Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators. (2022) (1)
- Prediction of incident atrial fibrillation in post-stroke patients using machine learning: a French nationwide study. (2022) (1)
- Futility risk model for predicting outcome after cardiac resynchronization therapy defibrillator implantation: data from a nationwide analysis (2021) (1)
- Season of Birth and Cardiovascular Mortality in Atrial Fibrillation: A Population-Based Cohort Study (2021) (1)
- Médicaments antiarhythmiques et insuffisances cardiaque (1995) (1)
- 179-05: Prevention of persistent AF: an ANSWER to the dilemma of long PR intervals versus reduction of ventricular pacing (2016) (1)
- Antiplatelet therapy strategies after percutaneous coronary intervention in patients needing oral anticoagulation. (2013) (1)
- A06-2 Decrease in recurrence of episodes and burden of atrial fibrillation using pacemaker diagnostics tools (2003) (1)
- P4748HASBLED score, frailty index or comorbidity index for bleeding risk assessment in patients with atrial fibrillation? (2019) (1)
- Prognosis of heart failure in idiopathic dilated cardiomyopathy: has it improved in tertiary referral centres over the last 10 years? (2004) (1)
- Editorial commentary: The CHA2DS2VASc score and its black and white items. (2019) (1)
- Outcomes in patients with acute myocardial infarction and a history of illicit drug use (2022) (0)
- Insuffisance rénale aiguë au cours de la prise en charge des endocardites infectieuses : incidence, facteurs de risque et pronostic (2018) (0)
- Effectiveness and Safety of the 15 Mg Dose of Rivaroxaban Compared with Vitamin k Antagonists in Patients with Atrial Fibrillation: Results from a Cohort Study in the Nationwide French Claims and Hospitalization Database (SNIIRAM) (2017) (0)
- Abstract 17137: Natural History of the Primary Prevention Implantable Cardioverter Defibrillator Therapy in France (2002-2012) (2014) (0)
- 0295: Increased intracardiac VEGF and VWF levels revealed low grade inflammatory process and progressive endothelial damage in patients with atrial fibrillation (2015) (0)
- When is a wearable defibrillator indicated? (2021) (0)
- Abstract 2454: Impact of Early Statin Therapy on Development of Atrial Fibrillation at the Acute Stage of Myocardial Infarction (2009) (0)
- Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer (2021) (0)
- Atrial Fibrillation Early Complicating Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention (2017) (0)
- Atrial Fibrillation and Oral Health (2021) (0)
- Atrial flutter: right, left, or both? (2012) (0)
- B-PO01-063 LATER ONSET OF FIRST SUSTAINED RBBB-VT AS COMPARED TO FIRST LBBB-VT IN PATIENTS WITH ARRHYTHMOGENIC CARDIOMYOPATHY (2021) (0)
- University of Birmingham Causes of death and influencing factors in patients with atrial fibrillation (2016) (0)
- Bleeding and thrombotic events in patients with atrial fibrillation and cancer: a systematic review and meta-regression analysis (2022) (0)
- Are Rotors Markers of Substrate or a Mechanism of Perpetuation of Atrial€Fibrillation? (2017) (0)
- IMPLICATION OF MULTIPLE RISK FACTORS IN PATIENTS WITH ISCHEMIC STROKE FOR SUBSEQUENT DIAGNOSIS OF ATRIAL FIBRILLATION (2014) (0)
- Prevalence of atrial arrhythmias in 48 hypertensive patients: a predictive positive factors research (1992) (0)
- 0171: Long-term outcome of possible and definite infective endocarditis in a population-based cohort study (2014) (0)
- Re-intervention for failed surgical aortic bioprosthesis: Remaining questions on long term outcomes and selection of patients. (2020) (0)
- 136 T2 mapping contribution in cardiac MRI examination: reversible oedema in dysfunctional myocardial segments in stress cardiomyopathy (2011) (0)
- 3575 Segmental wall motion abnormalities in idiopatic dilated cardiomyopathy: a common finding associated with a bad prognosis (2003) (0)
- Treatment recommendations and guidelines (2012) (0)
- L’insuffisance cardiaque diastolique chez les diabétiques non insulinodépendants est-elle favorisée par l’hypertension artérielle associée? Étude de 33 patients (1997) (0)
- Performance of the HAS‐BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database (2022) (0)
- For the benefit of our patients: The possibility of performing an MRI in the presence of a cardiac implantable electronic device must be maintained. (2022) (0)
- EVIEW rogramming implantable ardioverter-defibrillators in primary revention : Higher or later rogrammation des défibrillateurs implantables en prévention rimaire : plus haut ou plus tard (2014) (0)
- Cardiovascular outcomes in patients with cancer during a 5-year follow-up: Results from a French administrative database. (2023) (0)
- Abstract 12541: Features and Causes of Death of Patients With Atrial Fibrillation Seen in French Hospitals in 2012 (2014) (0)
- Prediction of Systemic Septic Embolism in Patients With Left-Sided Infective Endocarditis. (2017) (0)
- P869Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification (2018) (0)
- Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions (2023) (0)
- Abstract 18097: Predictors of Non-adherence with Guidelines for Antithrombotic Treatment and Subsequent Prognosis in Patients with Atrial Fibrillation. (2010) (0)
- Contents (2020) (0)
- Heart failure and cardiovascular outcomes in european patients with atrial fibrillation (2022) (0)
- P6083Predictors of atrial fibrillation ablation failure: a French nationwide cohort study (2018) (0)
- Mortality in patients with atrial fibrillation and heart failure. (2010) (0)
- Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation (2021) (0)
- Implantable cardiac defibrillator (ICD) in the setting of Tetralogy of Fallot (TOF): Data from the DAI-T4F National Registry (2018) (0)
- Incidence of clinical atrial fibrillation and related complications using a screening algorithm at a nationwide level. (2023) (0)
- P999Major adverse events with percutaneous left atrial appendage closure in patients with atrial fibrillation in real life setting (2019) (0)
- Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study. (2023) (0)
- Prediction of mortality and mode of death in heart failure using multimorbidity and clinical risk score systems: a nationwide analysis (2022) (0)
- radionuclide angioscintigraphy cardiomyopathy: A prognostic study with fourier phase analysis of Interventricular and intraventricular dyssynchrony in idiopathic dilated (2011) (0)
- An atypical intracardiac mass in a 61-year-old man (2014) (0)
- State-of-the-Art of Left Ventricular Assist Device use in France: the ASSIST-ICD registry (2017) (0)
- P3784Impact of progressively impaired renal function on major adverse outcomes in European patients with atrial fibrillation: a report from the ESC EORP-AF long-term general registry (2019) (0)
- The IC‐D score for predicting prophylactic cardioverter‐defibrillator implantation following acute myocardial infarction (2021) (0)
- Iconography : Extrasystoles auriculaires, jonctionnelles et ventriculaires (2010) (0)
- Abstract 16351: Aspirin or No Antithrombotic Therapy in Patients with Atrial Fibrillation and CHADS2 score=0 in a Real World Community Based Cohort Study (2012) (0)
- P4562Predictors of cardiovascular events in patients with atrial fibrillation after left atrial appendage closure for stroke prevention in a multicenter analysis (2017) (0)
- Prognoses of “high-profile” diseases: five-year survival following hospitalization with previous cancer compared to previous heart failure (2022) (0)
- EE156 Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure (HF) with Preserved Ejection Fraction (HFPEF) in France, Based on Emperor-Preserved Clinical Trial (2022) (0)
- 5050Evolution towards bradycardia-tachycardia syndrome in patients with atrial fibrillation or sinus node disease: a French nationwide cohort-study (2018) (0)
- 2396Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator (2019) (0)
- End-of-service management of leadless cardiac pacemakers: a case report. (2019) (0)
- Exploring the temporal relationship between atrial fibrillation and heart failure development. Analysis from nationwide database (2021) (0)
- Author response for "Metabolically Healthy Obesity and Cardiovascular Events. A Nationwide Cohort Study" (2021) (0)
- P832Persistence after initiation of oral anticoagulant for atrial fibrillation in France (2017) (0)
- Dual antiplatelet therapy after acute coronary syndrome: a cardiologist-based optimal decision (2015) (0)
- register myocardial infarction : data from the FAST-MI of atrial fibrillation at the acute stage of Impact of early statin therapy on development (0)
- Burden Of Cardiovascular Complications In Patients With Atrial Fibrillation In France. (2014) (0)
- Thromboembolic and bleeding risk stratification according to the EHRA valvular heart disease classification in patients with atrial fibrillation (2019) (0)
- Impact of body mass index on outcomes in European patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term registry (AFGen LT) (2020) (0)
- Statin and Atrial Fibrilation: When does it work? (2012) (0)
- Abstract 12605: Derivation and External Validation of a Cardiac Resynchronization Therapy Response Score (2015) (0)
- Comparison of bleeding risk scores in patients with atrial fibrillation and cancer (2021) (0)
- Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?". (2016) (0)
- Changes in incidences of clinical outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study since 2010 (2022) (0)
- Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation (2021) (0)
- Empagliflozin in Heart Failure. (2021) (0)
- Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level (2022) (0)
- O050 Prior history of falls and risk of cardiovascular outcomes in atrial fibrillation:The Loire Valley Atrial Fibrillation Project (2014) (0)
- Predictors of changes in glomerular filtration rate and outcomes in patients with atrial fibrillation (2019) (0)
- T Waves May Not Be What They Seem! (2023) (0)
- Risk of Thromboembolic Events without Oral Anticoagulation at 90 Days after Surgical Aortic Valve Replacement with a Bioprosthesis (2018) (0)
- 0444: Risk stratification for thromboembolic events in patients with atrial fibrillation and biological valve prosthesis (2016) (0)
- Development and In-Hospital Mortality of Transcatheter and Surgical Aortic Valve Replacement in 2015 in Germany (2018) (0)
- P6657Ischemic stroke in patient with sinus node disease in comparison to atrial fibrillation and bradycardia-tachycardia syndrome: a French nationwide cohort-study (2018) (0)
- Autoévaluations de l'article : Thérapeutique et problèmes généraux : antiarythmiques (2019) (0)
- 441 Sudden and non sudden death in idiopathic dilated cardiomyopathy. Analysis of a competitive risk and therapeutic implications (2005) (0)
- B-PO04-170 SEX DIFFERENCES IN PATIENTS WITH ARRHYTHMOGENIC CARDIOMYOPATHY WITH RESPECT TO VENTRICULAR TACHYCARDIA MORPHOLOGY (2021) (0)
- Atrial Fibrillation and the Risk of Ventricular Arrhythmias and Cardiac Arrest: A Nationwide Population-Based Study (2023) (0)
- 6 Implantable Loop Recorder in Clinical Practice (2018) (0)
- 1447 A benefit on recurrence of episodes and burden of atrial fibrillation using pacemaker diagnostics (2003) (0)
- Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction. (2022) (0)
- A validation of the 4S-AF scheme in Spanish and French patients from the EORP-AF Long-Term General Registry (2021) (0)
- P6230Catheter ablation for atrial fibrillation is associated with lower incidence of stroke: data from a French nationwide cohort study (2018) (0)
- Development of a claims-based EuroSCORE II in patients with aortic stenosis needing surgical or transcatheter aortic valve replacement using electronic hospital records: a nationwide study (2020) (0)
- Abstract 16369: Typical Atrial Flutter with and without Known Atrial Fibrillation: Benefit on Morbidity and Mortality After Cavotricuspid Isthmus Radiofrequency Catheter Ablation in a Controlled Nonrandomized Long-Term Study (2012) (0)
- Relations entre la variabilité du rythme sinusal et la capacité aérobie chez des enfants prépubères (2001) (0)
- Stroke incidence after catheter ablation for atrial fibrillation: Data from a French nationwide cohort study (2019) (0)
- Temporal changes in quality of life amongst European atrial fibrillation patients: relationship to all-cause mortality. A report from the ESC-EHRA EORP-AF General Long-Term Registry (2020) (0)
- P-418 Cost-effectiveness of telemedicine in implantable cardioverter defibrillator recipients according to distance between home and institution (2003) (0)
- 189 Similar implantable defibrillator event rates in patients with unexplained syncope and left ventricular dysfunction whatever the result of electrophysiological testing (2011) (0)
- COMPARISON OF THE LONG-TERM OUTCOME OF POSSIBLE AND DEFINITE INFECTIVE ENDOCARDITIS IN A POPULATION-BASED COHORT STUDY (2014) (0)
- Pacing for atrioventricular block. (2005) (0)
- Impact of type 2 diabetes on the incidence of cardiorenal syndromes and on subsequent clinical outcomes: a propensity-matched nationwide analysis (2022) (0)
- P4241Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different strategy needed in case of acute coronary syndrome? (2018) (0)
- Vitamin K antagonists and changes in glomerular filtration rate in patients with atrial fibrillation (2019) (0)
- P6564Prediction of the progression from paroxysmal to persistent or permanent atrial fibrillation using different scores. Is AF progression mainly atrial aging? (2019) (0)
- Impact of sinus node disease on atrial fibrillation prognosis: A community based cohort study (2018) (0)
- Bleeding risk prediction in a large cohort of patients with atrial fibrillation and cancer: a nationwide cohort study (2022) (0)
- MODERATED POSTERS SESSION: ATRIAL FIBRILLATION A 10-year prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project (2013) (0)
- Response to letter from Du et al. regarding article ‘Sodium‐glucose cotransporter‐2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?’ (2022) (0)
- P3591Impact of changing European guideline oral anticoagulation treatment thresholds on stroke and mortality in patients with atrial fibrillation (2017) (0)
- 0261: How to identify a risk for subsequent atrial fibrillation and higher risk of stroke in patients with hospitalization related to a cardiac cause? (2015) (0)
- P4820Benefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database (2018) (0)
- Nephrotic syndrome and acute coronary syndrome in children, teenagers and young adults: Systematic literature review. (2023) (0)
- A nationwide cohort study on the impact of gestational diabetes on future cardiovascular events (2022) (0)
- Relationship of aging and incident comorbidities to stroke risk in 594,169 Patients with atrial fibrillation: a nationwide analysis (2020) (0)
- Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General (2022) (0)
- Reply to the letter about the position paper concerning the competence, performance and environment required in the practice of complex ablation procedures. (2019) (0)
- Exploring the temporal relationship between atrial fibrillation and heart failure development (2021) (0)
- The atrial fibrillation registry in countries of Africa: Rationale and design of Africa (2018) (0)
- Risk of Ischaemic Stroke in Patients with Atrial Fibrillation and Concomitant Hyperthyroidism: A Nationwide Cohort Study (2021) (0)
- Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (2022) (0)
- [Indications for automatic implantable defibrillators in patients with the Brugada syndrome]. (2005) (0)
- [Screening and clinical implications of silent atrial fibrillation]. (2017) (0)
- P5505The efficacy and safety of the use of drug-eluting stents vs bare metal stents stratifying by antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting: a systematic review (2018) (0)
- Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project (2022) (0)
- P1794Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement (2019) (0)
- Therapeutic strategy in atrial fibrillation. (2003) (0)
- Reply (2020) (0)
- P2899Stroke, thromboembolism and bleeding events in patients with atrial fibrillation according to the new EHRA valvular heart disease classification (2018) (0)
- Antithrombotic management of atrial fibrillation (2013) (0)
- Reply (2018) (0)
- Impact of the timing of coronary revascularization relative to the transcatheter aortic valve implantation procedure: insights from a propensity score analysis based on a nationwide analysis (2020) (0)
- Rivaroxaban in Stable Cardiovascular Disease. (2018) (0)
- Infection and infective endocarditis after cardiac implantable electronic device implantation: a contemporary nationwide cohort study (2022) (0)
- 1127-107 Different criteria of cardiac resynchronization therapy have different prognostic value for worsening heart failure or major arrhythmic events in idiopathic dilated cardiomyopathy (2004) (0)
- Implementation of new technologies in automatic external defibrillators using guidelines for cardiopulmonary resuscitation. (2008) (0)
- Abstract 12373: Differences in Predictive Ability of HAS-BLED and HEMORR2HAGES in Patients With Atrial Fibrillation According to Age (2014) (0)
- Outcomes in patients with acute myocardial infarction and history of illicit drug use: a French nationwide analysis. (2021) (0)
- Abstract 16360: Is Oral Anticoagulation Needed in Patients with Coronary Artery Disease, Atrial Fibrillation and CHADS2 Score=0 or 1? A Real World Community Based Cohort Study (2012) (0)
- New Concepts for Management of Atrial Fibrillation (2015) (0)
- Clinical outcomes associated with left atrial appendage occlusion via implanted device in atrial fibrillation:a Nationwide Matched Control Study (2022) (0)
- Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed. (2018) (0)
- Clinical outcomes with ventricular pacing or dual-chamber pacing for sinus-node dysfunction: a nationwide matched control study (2021) (0)
- Long-term clinical outcomes in patients after catheter ablation for atrial fibrillation or atrioventricular node ablation: a French nationwide cohort study (2021) (0)
- Acute Decompensated Heart Failure, Volume, and Acetazolamide. (2022) (0)
- 66Clinical outcomes after catheter ablation for atrial fibrillation in elderly patients: a French nationwide cohort study (2019) (0)
- How to upgrade a leadless pacemaker to cardiac resynchronization therapy (2019) (0)
- P836Net clinical benefit of oral anticoagulation in very elderly patients with atrial fibrillation: something better than vitamin k antagonists needed? (2017) (0)
- How should we manage left atrial thrombosis? (2020) (0)
- 0173: Is oral anticoagulation needed in patients with atrial fibrillation, stent implantation and low-moderate risk of stroke? (2015) (0)
- Incidence of atrial fibrillation in patients with diabetes mellitus: effect of sex, age and type of diabetes in a nationwide analysis (2021) (0)
- P1870Predicting mortality and mode of death by clinical score systems for patients with atrial fibrillation (2019) (0)
- Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI- PP programme (pilot phase) Abbreviated title: ICDs for primary prevention of sudden cardiac death (2019) (0)
- WHAT ARE THE DIFFERENCES IN ORAL ANTICOAGULANT TREATMENT PERSISTENCE IN NON-VALVULAR ATRIAL FIBRILLATION IN EUROPE? REAL-WORLD STUDIES IN THREE EUROPEAN COUNTRIES (2017) (0)
- Characteristics and survival of patients with advanced heart failure treated with left ventricular assist device (LVAD) as an effective bridge to heart transplantation vs. destination therapy through a French national retrospective cohort (2023) (0)
- Traitement chirurgical de la fibrillation auriculaire (1994) (0)
- Enjeux cliniques morbi-mortalité, risques thromboemboliques (2009) (0)
- Rapid Ventricular Tachycardia in Patients with Tetralogy of Fallot and Implantable Cardioverter-Defibrillator. Insights from the DAI-T4F Nationwide Registry. (2022) (0)
- Documents légaux de l'article : Antiarythmiques (2013) (0)
- Surveillance après stimulation atrio-ventriculaire (2006) (0)
- EVIEW ow to define valvular atrial fibrillation ? omment définir la fibrillation atriale valvulaire ? (2015) (0)
- Insuffisance cardiaque : Deux guides selon l'atteinte de la fonction systolique (2007) (0)
- Comment définir la fibrillation atriale valvulaire (2015) (0)
- Epidémiologie des syncopes (2022) (0)
- Diabète de type 2 et syndromes cardio-rénaux dans la cohorte nationale française (2022) (0)
- Des médicaments non anti-arythmiques peuvent-ils avoir un effet préventif sur la fibrillation auriculaire ? (2010) (0)
- Thérapeutique et problèmes généraux : antiarythmiques (2019) (0)
- Maladie coronarienne : Le patient coronarien ne peut se passer de traitement antiagrégant (2007) (0)
- Variabilité du rythme sinusal (2000) (0)
- Électrophysiologie et rythmologie (2004) (0)
- Iconographies supplémentaires de l'article : Thérapeutique et problèmes généraux : antiarythmiques (2019) (0)
- Anémie hémolytique sévère survenant 10 ans après hétérogreffe mitrale (1996) (0)
- Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in patients with pacemakers and implantable cardioverter defibrillators (ICDs) (2022) (0)
- Les syncopes des obstacles à l'éjection ventriculaire gauche (1994) (0)
- P6589The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project (2018) (0)
- L'année 2002 en rythmologie : pour des changements radicaux ? (2003) (0)
- BNP et diagnostic d’insuffisance cardiaque en urgence (2003) (0)
- Points de vue et images du monde des arythmies auriculaires (2003) (0)
- Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry (2021) (0)
- Arbres décisionnels de l'article : Thérapeutique et problèmes généraux : antiarythmiques (2019) (0)
- Place du délai de prise en charge dans la stratégie de revascularisation à la phase aiguë de l'infarctus du myocarde : Données issues de la vie réelle (2006) (0)
- Asynchronisme et resynchronisation ventriculaire (2009) (0)
- Arbres décisionnels de l'article : Antiarythmiques (2013) (0)
- Rythmologie, stimulation et défibrillation (2005) (0)
- Prediction of mortality and mode of death by clinical risk score systems in 2.6 million patients with atrial fibrillation: a nationwide analysis (2020) (0)
- Impact on outcomes in Europe: a cluster analysis from the ESC-EHRA EORP AF general long-term registry (2021) (0)
- Défibrillateur implantable prophylactique et stimulation biventriculaire dans l'insuffisance cardiaque (2002) (0)
- Association between thromboembolic and bleeding risk with adverse outcomes in contemporary European atrial fibrillation patients: final analysis from the ESC-EHRA EORP AF general long-term registry (2021) (0)
- [Points of view and images of the world of atrial arrhythmias]. (2003) (0)
- ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation (2022) (0)
- Left atrial strain as a predictive factor of new-onset silent atrial fibrillation after acute myocardial infarction (2017) (0)
- 0358: Incidence and predictors of major haemorrhagic complications in pulmonary embolism patients receiving thrombolytic therapy (2016) (0)
- P4809Possible benefits of left atrial appendage closure for stroke prevention in patients with atrial fibrillation in real life setting (2018) (0)
- Signal-averaged electrocardiogram readings predict cardiac death and events in people with dilated cardiomyopathy (2001) (0)
- 0291: Incremental value of copeptin with high sensitivity cardiac T troponin for exclusion of severe coronary stenosis in patients with preexisting coronary artery disease (2016) (0)
- Benefit-Risk And Medical Costs of Rivaroxaban 15mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation (2017) (0)
- Autoévaluations de l'article : Antiarythmiques (2013) (0)
- Modeling the impact of the new European Heart Rhythm Association algorithm for atrial fibrillation screening using new digital tools (2023) (0)
- Sustained ventricular tachycardia of left, right or both bundle branch block morphology in patients with Arrhythmogenic Cardiomyopathy (2020) (0)
- P956 The reliability of QRS duration and morphology on surface electrocardiogram to identify ventricular dyssynchrony. A Fourier phase analysis of angioscintigraphy (2003) (0)
- 4070Clinical impact of mitral regurgitation before or following transcatheter aortic valve replacement in patients with aortic stenosis: a nationwide multivariable analysis (2019) (0)
- Antidiabetic agents and their hypothetical benefit on the risk of cardiac arrhythmias. (2022) (0)
- P1717Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation (2017) (0)
- 0128: CHA2DS2-VASc score estimates in-hospital mortality beyond GRACE score after acute myocardial infarction (2016) (0)
- This uncertainty in treatment guidance ... leads to significant differences in the prescription of anticoagulation and antiplatelet therapy among these patients ... and is finally subject to physician discretion and patient preference ... (2010) (0)
- Leadless or Conventional Transvenous Ventricular Permanent Pacemakers: A Nationwide Matched Control Study (2021) (0)
- P4585Long-term follow-up of silent and symptomatic atrial fibrillations during acute myocardial infarction: not an epiphenomenon (2017) (0)
- 231 Circumferential pulmonary vein isolation with a cryoballoon: safety, efficacy and follow-up (experience of the rythmology Unit, CHU Grenoble) (2010) (0)
- P1160Outcomes in patients with ablation of clockwise vs counterclockwise forms of typical atrial flutter (2018) (0)
- Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis (2022) (0)
- Predicting left ventricular reverse remodeling as well as outcome after cardiac resynchronization therapy with a score combining clinical, electrocardiographic, and echocardiographic parameters (2015) (0)
- P2761 Aortic ejection delay is a better predictor of ventricular dyssynchrony and severity of the haemodynamic status than interventricular delay (2003) (0)
- Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in the general population (2022) (0)
- Long-term follow-up of silent and symptomatic atrial fibrillations during acute myocardial infarction: Not an epiphenomenon! (2018) (0)
- Benefit-Risk And Medical Costs of Rivaroxaban 20mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation (2017) (0)
- Prognosis of Atrial Fibrillation with or without Comorbidities: Analysis of Younger Adults from a Nationwide Database (2022) (0)
- Abstract 14715: Diabetes and Relative Rates of Cardiovascular Events in Women Compared With Men (2020) (0)
- DETERMINANTS AND PROGNOSTIC VALUE OF BRAIN NATRIURETIC PEPTIDE (BNP) FOR CARDIOVASCULAR EVENTS IN A COHORT OF PATIENTS WITH ATRIAL FIBRILLATION (2014) (0)
- Reply to ‘Digoxin and beta‐blockers in patients with heart failure’. Letter regarding the article ‘Clinical outcomes with digoxin vs. beta‐blocker for heart rate control in permanent atrial fibrillation with heart failure’ (2022) (0)
- Atrial fibrillation with our with-out structural abnormalities (2021) (0)
- [What to do in patient with atrial fibrillation when interventional gesture is programmed?]. (2013) (0)
- Abstract 2864: Antiarrhythmic Effect of Statins and Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials. (2007) (0)
- Myocardial Revascularization Strategies in ST Elevation Myocardial Infarction Without Urgent Revascularization: Insight From a Nationwide Study. (2022) (0)
- 0356: Prognostic value of CHA2DS2-VASc score in patients with atrial fibrillation and valvular heart disease (2014) (0)
- Should antithrombotic therapy be different in patients with atrial fibrillation and a so-called temporary cause and especially after an acute coronary syndrome? (2019) (0)
- Cardiovascular events in metabolically healthy obese. A nationwide cohort study (2021) (0)
- 0189: Identification of risk factors for embolic events in left-sided infective endocarditis (2015) (0)
- Aalborg Universitet Decision-Making in Clinical Practice (2016) (0)
- Outcomes in patients with acute myocardial infarction and a history of illicit drug use: a nationwide analysis (2020) (0)
- INCIDENT ATRIAL FIBRILLATION ACCORDING TO GENDER IN PATIENTS WITH ISCHEMIC STROKE: A NATIONWIDE COHORT STUDY (2017) (0)
- Original InvestigationWITHDRAWAL: Prediction of Nonarrhythmic Mortality in Primary Prevention Implantable Cardioverter-Defibrillator Patients With Ischemic and Nonischemic Cardiomyopathy (2015) (0)
- Abstract 14762: Stroke and Thromboembolism in Patients With Atrial Fibrillation and Mitral Regurgitation (2016) (0)
- All-cause mortality and cardiovascular death in 52091 patients with hypertrophic cardiomyopathy. A nationwide cohort study (2021) (0)
- Acute myocarditis with autoimmune features: one-year follow-up with CMR (2021) (0)
- Conclusions:Recurrence of AF and complication rate after a single PVI procedure were not statistically different for LB PVI as compared to standard RF PVI. P1404 Contact force implementation in routine clinical practice: results from a french national survey (2017) (0)
- April 07th, Thursday 20160136 : CHA2DS2VASc score estimates in-hospital mortality beyond GRACE score after acute myocardial infarction (2016) (0)
- Answer to the letter of Walid Amara et al. (2018) (0)
- P835Prognosis in patients with atrial fibrillation and sinus node disease in a community based cohort study (2017) (0)
- Compared prognostic impact of incident atrial fibrillation versus history of atrial fibrillation in patients with AMI: the FAST-MI programme (2020) (0)
- Infection and infective endocarditis according to type of diabetes mellitus after cardiac implantable electronic device implantation: a contemporary nationwide cohort study (2022) (0)
- LONG-TERM OUTCOME OF A REAL LIFE POPULATION-BASED COHORT WITH INFECTIVE ENDOCARDITIS (2014) (0)
- Exploration de perturbations spécifiques du systèpme cardiovasculaire par l'étude de la variabilité du rythme sinusal (2000) (0)
- 0165: Long-term outcome in a systematic analysis of a population-based cohort with infective endocarditis (2014) (0)
- Incident arrhythmias, heart failure and cardiovascular outcomes with SGLT-2 inhibitor use in diabetic patients: Insights from a global federated electronic medical record database (2022) (0)
- Rhythm versus rate control therapy and subsequent stroke/thromboembolic events in patients with atrial fibrillation (2013) (0)
- Galectin-3 predicts response and outcomes after cardiac resynchronization therapy (2018) (0)
- 0370: Effect of smoking on comparative efficacy of antithrombotic therapy in patients with atrial fibrillation. A community based cohort study (2014) (0)
- G001 Interventricular delay assessed by equilibrium radionuclide angiography as a predictor of clinical response to cardiac resynchronization therapy (2009) (0)
- Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (2022) (0)
- Distal‐to‐proximal delay for ablation of premature ventricular contractions (2019) (0)
- 680Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different benefit in case of acute coronary syndrome? (2018) (0)
- P1404Contact force implementation in routine clinical practice: results from a french national survey (2017) (0)
- P1283New insights on the pathogenesis of atrial fibrillation in acute myocardial infarction: data from the RICO survey (2018) (0)
- Clinical Phenotypes and Atrial Fibrillation Recurrences after Catheter Ablation: An Unsupervised Cluster Analysis. (2023) (0)
- Comparison of stroke risk according to sinus node disease, atrial fibrillation and bradycardia-tachycardia syndrome: A French nationwide cohort-study (2019) (0)
- Is there a white-coat effect for heart rate in heart failure? Characteristics and prognostic implications in patients with idiopathic dilated cardiomyopathy (2017) (0)
- Evolving changes of outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study (2022) (0)
- P6576Use of atrioventricular nodal ablation after atrial fibrillation ablation failure: a nationwide cohort study (2019) (0)
- Cyclosporine A to reduce myocardial reperfusion injury: A systematic review and meta-analysis of randomized controlled trials (2018) (0)
- Pacemakers and implantable cardiac defibrillators: Must we fear hackers? Cybersecurity of implantable electronic devices. (2023) (0)
- HEART RATE VARIABILITY AND PROGNOSIS IN CORONARY ARTERY DISEASE. AUTHORS' REPLY (1999) (0)
- Reply: Chocolate Trials. (2020) (0)
- Outcomes Following Aortic Stenosis Treatment (Transcatheter vs Surgical Replacement) in Women vs Men (From a Nationwide Analysis). (2021) (0)
- Abstract 20207: Lower Risk in Young Patients Aged < 50 With Atrial Fibrillation and Low CHA2DS2-VASc Risk Score (2017) (0)
- [Which antithrombotic treatment in case of atrial fibrillation and coronary heart disease?]. (2013) (0)
- Improved Outcomes of Pediatric Dilated Cardiomyopathy and Heart Transplantation (2016) (0)
- Age, sex and clinical outcomes with digoxin vs beta-blocker in permanent atrial fibrillation with heart failure. (2021) (0)
- Letter by Marín et al regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study". (2013) (0)
- Effect of cardiorenal syndrome and its different subtypes on incidence of atrial fibrillation in a nationwide analysis (2022) (0)
- Adverse Cardiovascular Events in Non-Traumatic Intracranial Hemorrhage and Ischemic Stroke Survivors (2022) (0)
- 655 Heart failure and atrial fibrillation. Prognosis with beta blocker and digoxin alone or in combination (2008) (0)
- Balancing the risks of adverse events and optimal programming of implantable cardioverter-defibrillators: Authors' reply. (2019) (0)
- Abstract 14575: Implantable Cardiac Defibrillator in the Setting of Tetralogy of Fallot: Long-Term Follow-Up of a French National Multicenter Retrospective Registry (2015) (0)
- Mortality after atrioventricular nodal radiofrequency catheter ablation in atrial fibrillation: outcomes from a controlled nonrandomized long-term study (2013) (0)
- Long-term outcomes in patients with ablation of clockwise and counterclockwise forms of typical atrial flutter (2018) (0)
- Mortality and Major Cardiovascular Events among Patients with Multiple Myeloma: Analysis from a Nationwide French Medical Information Database (2022) (0)
- 230 Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective continuous monitoring study (2010) (0)
- A 10-year prospective study of estimated glomerular filtration rate and outcomes with oral anticoagulation in patients with atrial fibrillation (2013) (0)
- 5718Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis (2017) (0)
- 201Left atrial appendage closure for stroke prevention in patients with atrial fibrillation: the difficult task of estimating the possible benefit in real life setting (2018) (0)
- Prevalence and Incidence of Cardiovascular and Renal Diseases in Type 1 Compared with Type 2 Diabetes: A Nationwide French Observational Study of Hospitalized Patients. (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Laurent Fauchier?
Laurent Fauchier is affiliated with the following schools:
